×

BRIEF-Celgene updates on FDA advisory committee for Pomalidomide

Oct 3 (Reuters) - Celgene Corp :

* Provides update on FDA advisory committee for Pomalidomide

* Notified by the U.S. FDA there will not be oncologic drugs advisory committee

meeting scheduled for November 8, 2012

* FDA informed co review of nda for Pomalidomide continuing with PDUFA action

date remaining February 10, 2013

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))